Skip to main content

Table 1 Correlation between CASC11 and clinicopathological characteristics (n = 50)

From: LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway

Clinicopathologic feature

N (%)

CASC11 (mean ± SEM)

p-value

Age

0.836

 ≤ 60

19 (38%)

1.23 ± 0.17

 

 > 60

31 (62%)

1.17 ± 0.20

 

Tumor size (cm)

0.047*

 < 4

38 (76%)

1.05 ± 0.12

 

 ≥ 4

12 (24%)

1.42 ± 0.15

 

Menopause

 

 Yes

26 (52%)

1.29 ± 0.17

0.925

 No

24 (48%)

1.30 ± 0.14

 

Lymph node metastasis

 

 Negative

23 (46%)

1.25 ± 0.20

0.918

 Positive

27 (54%)

1.27 ± 0.18

 

Lymphativ vascular space invasion

 

 Negative

29 (58%)

1.23 ± 0.12

0.816

 Positive

21 (42%)

1.36 ± 0.10

 

FIGO stage

0.043*

 I

38 (78%)

1.03 ± 0.15

 

 II

12 (24%)

1.39 ± 0.16

 
  1. *p < 0.5